Abstract
Chagas’ disease, caused by Trypanosoma cruzi, has been considered a paradigm of infection-induced autoimmune disease. Thus, the scarcity of parasites in the chronic phase of the disease contrasts with the severe cardiac pathology observed in approximately 30% of chronic patients and suggested a role for autoimmunity as the origin of the pathology. Antigen-specific and antigen-non-specific mechanisms have been described by which T. cruzi infection might activate T and B cells, leading to autoimmunity. Among the first mechanisms, molecular mimicry has been claimed as the most important mechanism leading to autoimmunity and pathology in the chronic phase of this disease. In this regard, various T. cruzi antigens, such as B13, cruzipain and Cha, cross-react with host antigens at the B or T cell level and their role in pathogenesis has been widely studied. Immunization with those antigens and/or passive transfer of autoreactive T lymphocytes in mice lead to clinical disturbances similar to those found in Chagas’ disease patients. On the other hand, the parasite is becoming increasingly detected in chronically infected hosts and may also be the cause of pathology either directly or through parasite-specific mediated inflammatory responses. Thus, the issue of autoimmunity versus parasite persistence as the cause of Chagas’ disease pathology is hotly debated among many researchers in the field. We critically review here the evidence in favor of and against autoimmunity through molecular mimicry as responsible for Chagas’ disease pathology from clinical, pathological and immunological perspectives.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abel, LC, Kalil, J, Cunha Neto, E (1997) Molecular mimicry between cardiac myosin and Trypanosoma cruzi antigen B13: identification of a B13-driven human T cell clone that recognizes cardiac myosin. Braz J Med Biol Res 30:1305–1308
Acosta, AM, Santos-Buch, CA (1985) Autoimmune myocarditis induced by Trypanosoma cruzi. Circulation 71:1255–1261
Aliberti, JC, Cardoso, MA, Martins, GA, Gazzinelli, RT, Vieira, LQ, Silva, JS (1996) Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect Immun 64:1961–1967
Almeida, HO, Teixeira, VP, Gobbi, H, Rocha, A, Brandao, MC (1984) [Inflammation associated with cardiac muscle cells parasitized by Trypanosoma cruzi, in chronic Chagas’ disease patients]. Arq Bras Cardiol 42:183–186
Andrade, ZA, Andrade, SG (1955) The pathology of Chagas’ disease. (cardiac chronic form). Bol Fund G Moniz 6:1–53
Aznar, C, Lopez-Bergami, P, Brandariz, S, Mariette, C, Liegeard, P, Alves, MD, Barreiro, EL, Carrasco, R, Lafon, S, Kaplan, D, et al. (1995) Prevalence of anti-R-13 antibodies in human Trypanosoma cruzi infection. FEMS Immunol Med Microbiol 12:231–238
Ben Younes-Chennoufi, A, Hontebeyrie-Joskowicz, M, Tricottet, V, Eisen, H, Reynes, M, Said, G (1988) Persistence of Trypanosoma cruzi antigens in the inflammatory lesions of chronically infected mice. Trans R Soc Trop Med Hyg 82:77–83
Benoist, C, Mathis, D (2001) Autoimmunity provoked by infection: how good is the case for T cell epitope mimicry? Nat Immunol 2:797–801
Benvenuti, LA, Higuchi, ML, Reis, MM (2000) Upregulation of adhesion molecules and class I HLA in the myocardium of chronic chagasic cardiomyopathy and heart allograft rejection, but not in dilated cardiomyopathy. Cardiovasc Pathol 9:111–117
Buckner, FS, Wilson, AJ, Van Voorhis, WC (1999) Detection of live Trypanosoma cruzi in tissues of infected mice by using histochemical stain for beta-galactosidase. Infect Immun 67:403–409
Burleigh, BA, Andrews, NW (1998) Signaling and host cell invasion by Trypanosoma cruzi. Curr Opin Microbiol 1:461–465
Carrasco Guerra, HA, Palacios-Pru, E, Dagert de Scorza, C, Molina, C, Inglessis, G, Mendoza, RV (1987) Clinical, histochemical, and ultrastructural correlation in septal endomyocardial biopsies from chronic chagasic patients: detection of early myocardial damage. Am Heart J 113:716–724
Castanos-Velez, E, Maerlan, S, Osorio, LM, Aberg, F, Biberfeld, P, Orn, A, Rottenberg, ME (1998) Trypanosoma cruzi infection in tumor necrosis factor receptor p55-deficient mice. Infect Immun 66:2960–2968
Cazzulo, JJ, Frasch, AC (1992) SAPA/trans-sialidase and cruzipain: two antigens from Trypanosoma cruzi contain immunodominant but enzymatically inactive domains. FASEB J 6:3259–3264
Chagas C (1909) Nova tripanozomiaze humana. Estudos sobre a morfolojia e o ciclo evolutivo do Schitrypanum cruzi n. gen., n. sp. Ajente etiolojico de nova entidade morbida do homen. Mem. Inst. Oswaldo Cruz 1:159–219
Cossio, PM, Bustuoabad, O, Paterno, E, Iotti, R, Casanova, MB, Podesta, MR, Bolomo, N, Arana, RM, de Pasqualini, CD (1984) Experimental myocarditis induced in Swiss mice by homologous heart immunization resembles chronic experimental Chagas’ heart disease. Clin Immunol Immunopathol 33:165–175
Cossio, PM, Diez, C, Szarfman, A, Kreutzer, E, Candiolo, B, Arana, RM (1974a) Chagasic cardiopathy. Demonstration of a serum gamma globulin factor which reacts with endocardium and vascular structures. Circulation 49:13–21
Cossio, PM, Laguens, RP, Diez, C, Szarfman, A, Segal, A, Arana, RM (1974b) Chagasic cardiopathy. Antibodies reacting with plasma membrane of striated muscle and endothelial cells. Circulation 50:1252–1259
Cuhna-Neto, EaK, J. (2000) Molecular mimicry and Chagas’ disease. Microbes and Autoimmunity ASM Press 245–257
Cunha-Neto, E, Coelho, V, Guilherme, L, Fiorelli, A, Stolf, N, Kalil, J (1996) Autoimmunity in Chagas’ disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas’ cardiomyopathy patient. J Clin Invest 98:1709–1712
Cunha-Neto, E, Gruber, A, Zingales, B, De Messias, I, Stolf, N, Bellotti, G, Patarroyo, ME, Pilleggi, F, Kalil, J (1995) Autoimmunity in Chagas disease cardiopathy: biological relevance of a cardiac myosin-specific epitope crossreactive to an immunodominant Trypanosoma cruzi antigen. Proc Natl Acad Sci U S A 92:3541–3545
Cunha-Neto, E, Kalil, J (2001) Heart-infiltrating and peripheral T cells in the pathogenesis of human Chagas’ disease cardiomyopathy. Autoimmunity 34:187–192
Cunha-Neto, E, Kei, L, Morand, A, Gonçalves, S, Kalil, J. (2004). Autoimmunity in Chagas disease, pp. 449–466. Elsevier.
Cunha-Neto, E, Moliterno, R, Coelho, V, Guilherme, L, Bocchi, E, Higuchi Mde, L, Stolf, N, Pileggi, F, Steinman, L, Kalil, J (1994) Restricted heterogeneity of T cell receptor variable alpha chain transcripts in hearts of Chagas’ disease cardiomyopathy patients. Parasite Immunol 16:171–179
Cunha-Neto, E, Rizzo, LV, Albuquerque, F, Abel, L, Guilherme, L, Bocchi, E, Bacal, F, Carrara, D, Ianni, B, Mady, C, Kalil, J (1998) Cytokine production profile of heart-infiltrating T cells in Chagas’ disease cardiomyopathy. Braz J Med Biol Res 31:133–137
Cunningham, MW (2004) T cell mimicry in inflammatory heart disease. Mol Immunol 40:1121–1127
Davila, DF, Donis, JH, Torres, A, Gottberg, CF, Rossell, O (1991) Cardiac parasympathetic innervation in Chagas’ heart disease. Med Hypotheses 35:80–84
Davila, DF, Rossell, O, de Bellabarba, GA (2002) Pathogenesis of chronic chagas heart disease: parasite persistence and autoimmune responses versus cardiac remodelling and neurohormonal activation. Int J Parasitol 32:107–109
de Scheerder, IK, de Buyzere, ML, Delanghe, JR, Clement, DL, Wieme, RJ (1989) Anti-myosin humoral immune response following cardiac injury. Autoimmunity 4:51–58
Dias, E, Laranja, FS, Miranda, A, Nobrega, G (1956) Chagas’ disease; a clinical, epidemiologic, and pathologic study. Circulation 14:1035–1060
dos Santos, PV, Roffe, E, Santiago, HC, Torres, RA, Marino, AP, Paiva, CN, Silva, AA, Gazzinelli, RT, Lannes-Vieira, J (2001) Prevalence of CD8(+)alpha beta T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L(Low)LFA-1(High)VLA-4(High) activation phenotype and expression of IFN-gamma-inducible adhesion and chemoattractant molecules. Microbes Infect 3:971–984
dos Santos, RR, Rossi, MA, Laus, JL, Silva, JS, Savino, W, Mengel, J (1992) Anti-CD4 abrogates rejection and reestablishes long-term tolerance to syngeneic newborn hearts grafted in mice chronically infected with Trypanosoma cruzi. J Exp Med 175:29–39
Eisen, H, Kahn, S (1991) Mimicry in Trypanosoma cruzi: fantasy and reality. Curr Opin Immunol 3:507–510
Elies, R, Ferrari, I, Wallukat, G, Lebesgue, D, Chiale, P, Elizari, M, Rosenbaum, M, Hoebeke, J, Levin, MJ (1996) Structural and functional analysis of the B cell epitopes recognized by anti-receptor autoantibodies in patients with Chagas’ disease. J Immunol 157:4203–4211
Elkon, K, Skelly, S, Parnassa, A, Moller, W, Danho, W, Weissbach, H, Brot, N (1986) Identification and chemical synthesis of a ribosomal protein antigenic determinant in systemic lupus erythematosus. Proc Natl Acad Sci U S A 83:7419–7423
Engman, DM, Leon, JS (2002) Pathogenesis of Chagas heart disease: role of autoimmunity. Acta Trop 81:123–132
Factor, SM, Cho, S, Wittner, M, Tanowitz, H (1985) Abnormalities of the coronary microcirculation in acute murine Chagas’ disease. Am J Trop Med Hyg 34:246–253
Fedoseyeva, EV, Zhang, F, Orr, PL, Levin, D, Buncke, HJ, Benichou, G (1999) De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J Immunol 162:6836–6842
Fernandez, MA, Munoz-Fernandez, MA, Fresno, M (1993) Involvement of beta 1 integrins in the binding and entry of Trypanosoma cruzi into human macrophages. Eur J Immunol 23:552–557
Ferrari, I, Levin, MJ, Wallukat, G, Elies, R, Lebesgue, D, Chiale, P, Elizari, M, Rosenbaum, M, Hoebeke, J (1995) Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1-adrenergic receptor. J Exp Med 182:59–65
Ferreira, MS, Borges, AS (2002) Some aspects of protozoan infections in immunocompromised patients—a review. Mem Inst Oswaldo Cruz 97:443–457
Fourneau, JM, Bach, JM, van Endert, PM, Bach, JF (2004) The elusive case for a role of mimicry in autoimmune diseases. Mol Immunol 40:1095–1102
Fresno, M, Kopf, M, Rivas, L (1997) Cytokines and infectious diseases. Immunol Today 18:56–58
Gazzinelli, RT, Oswald, IP, Hieny, S, James, SL, Sher, A (1992) The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an l-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur J Immunol 22:2501–2506
Giordanengo, L, Fretes, R, Diaz, H, Cano, R, Bacile, A, Vottero-Cima, E, Gea, S (2000a) Cruzipain induces autoimmune response against skeletal muscle and tissue damage in mice. Muscle Nerve 23:1407–1413
Giordanengo, L, Maldonado, C, Rivarola, HW, Iosa, D, Girones, N, Fresno, M, Gea, S (2000b) Induction of antibodies reactive to cardiac myosin and development of heart alterations incruzipain-immunized mice and their offspring. Eur J Immunol 30:3181–3189
Girones, N, Cuervo, H, Fresno, M (2004) Is there a pathogenic role of autoimmune response in Chagas’ disease. ImmunologÍa 23:185–199
Girones, N, Rodriguez, CI, Basso, B, Bellon, JM, Resino, S, Munoz-Fernandez, MA, Gea, S, Moretti, E, Fresno, M (2001a) Antibodies to an epitope from the Cha human autoantigen are markers of Chagas’ disease. Clin Diagn Lab Immunol 8:1039–1043
Girones, N, Rodriguez, CI, Carrasco-Marin, E, Hernaez, RF, de Rego, JL, Fresno, M (2001b) Dominant T-and B-cell epitopes in an autoantigen linked to Chagas’ disease. J Clin Invest 107:985–993
Goni, O, Alcaide, P, Fresno, M (2002) Immunosuppression during acute Trypanosoma cruzi infection: involvement of Ly6G (Gr1+)CD11b+ immature myeloid suppressor cells. Int Immunol 14:1125–1134
Gruber, A, Zingales, B (1993) Trypanosoma cruzi: characterization of two recombinant antigens with potential application in the diagnosis of Chagas’ disease. Exp Parasitol 76:1–12
Guarner, J, Bartlett, J, Zaki, SR, Colley, DG, Grijalva, MJ, Powell, MR (2001) Mouse model for Chagas disease: immunohistochemical distribution of different stages of Trypanosoma cruzi in tissues throughout infection. Am J Trop Med Hyg 65:152–158
Henriques-Pons, A, Oliveira, GM, Paiva, MM, Correa, AF, Batista, MM, Bisaggio, RC, Liu, CC, Cotta-De-Almeida, V, Coutinho, CM, Persechini, PM, Araujo-Jorge, TC (2002) Evidence for a perforin-mediated mechanism controlling cardiac inflammation in Trypanosoma cruzi infection. Int J Exp Pathol 83:67–79
Higuchi Mde, L, Benvenuti, LA, Martins Reis, M, Metzger, M (2003) Pathophysiology of the heart in Chagas’ disease: current status and new developments. Cardiovasc Res 60:96–107
Higuchi, ML, Brito, T., Reis, M. et al. (1993)Correlation between T. cruziand myocardial inflammation in human chronic chagasic myocarditis. Light microscopy and immunohistochemical findings. Cardiovasc Pathol 2:101–106
Higuchi, ML, De Morais, CF, Pereira Barreto, AC, Lopes, EA, Stolf, N, Bellotti, G, Pileggi, F (1987) The role of active myocarditis in the development of heart failure in chronic Chagas’ disease: a study based on endomyocardial biopsies. Clin Cardiol 10:665–670
Hoff, R, Teixeira, RS, Carvalho, JS, Mott, KE (1978) Trypanosoma cruzi in the cerebrospinal fluid during the acute stage of Chagas’ disease. N Engl J Med 298:604–606
Holscher, C, Kohler, G, Muller, U, Mossmann, H, Schaub, GA, Brombacher, F (1998) Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect Immun 66:1208–1215
Jones, EM, Colley, DG, Tostes, S, Lopes, ER, Vnencak-Jones, CL, McCurley, TL (1993) Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg 48:348–357
Kalil, J, Cunha-Neto, E (1996) Autoimmunity in Chagas disease cardiomyopathy: Fulfilling the criteria at last? Parasitol Today 12:396–399
Kaplan, D, Ferrari, I, Bergami, PL, Mahler, E, Levitus, G, Chiale, P, Hoebeke, J, Van Regenmortel, MH, Levin, MJ (1997) Antibodies to ribosomal P proteins of Trypanosoma cruzi in Chagas disease possess functional autoreactivity with heart tissue and differ from anti-P autoantibodies in lupus. Proc Natl Acad Sci U S A 94:10301–10306
Kaplan, D, Vazquez, M, Lafon, S, Schijman, AG, Levitus, G, Levin, MJ (1993) The chronic presence of the parasite, and anti-P autoimmunity in Chagas disease: the Trypanosoma cruzi ribosomal P proteins, and their recognition by the host immune system. Biol Res 26:273–277
Kierszenbaum, F (1986) Autoimmunity in Chagas’ disease. J Parasitol 72:201–211
Kierszenbaum, F (1999) Chagas’ disease and the autoimmunity hypothesis. Clin Microbiol Rev 12:210–223
Kierszenbaum, F (2003) Views on the autoimmunity hypothesis for Chagas disease pathogenesis. FEMS Immunol Med Microbiol 37:1–11
Kim, EY, Teh, HS (2001) TNF type 2 receptor (p75) lowers the threshold of T cell activation. J Immunol 167:6812–6820
Kirchhoff, LV (1989) Is Trypanosoma cruzi a new threat to our blood supply? Ann Intern Med 111:773–775
Kirchhoff, LV (1993) Chagas disease. American trypanosomiasis. Infect Dis Clin North Am 7:487–502
Koberle, F (1961) [Pathology and pathological anatomy of Chagas’ disease]. Bol Oficina Sanit Panam 51:404–428
Koberle, F (1970) The causation and importance of nervous lesions in American trypanosomiasis. Bull World Health Organ 42:739–743
Koberle, F, Nador, E (1955) Rev Paul Med 47:643–661
Kumar, S, Tarleton, RL (1998) The relative contribution of antibody production and CD8+ T cell function to immune control of Trypanosoma cruzi. Parasite Immunol 20:207–216
Lanzavecchia, A (1995) How can cryptic epitopes trigger autoimmunity? J Exp Med 181:1945–1948
Laucella, SA, Postan, M, Martin, D, Hubby Fralish, B, Albareda, MC, Alvarez, MG, Lococo, B, Barbieri, G, Viotti, RJ, Tarleton, RL (2004) Frequency of interferongamma-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J Infect Dis 189:909–918
Laucella, SA, Segura, EL, Riarte, A, Sosa, ES (1999) Soluble platelet selectin (sP-selectin) and soluble vascular cell adhesion molecule-1 (sVCAM-1) decrease during therapy with benznidazole in children with indeterminate form of Chagas’ disease. Clin Exp Immunol 118:423–427
Leiros, CP, Sterin-Borda, L, Borda, ES, Goin, JC, Hosey, MM (1997) Desensitization and sequestration of human m2 muscarinic acetylcholine receptors by autoantibodies from patients with Chagas’ disease. J Biol Chem 272:12989–12993
Leon, JS, Daniels, MD, Toriello, KM, Wang, K, Engman, DM(2004) A cardiac myosinspecific autoimmune response is induced by immunization with Trypanosoma cruzi proteins. Infect Immun 72:3410–3417
Leon, JS, Engman, DM (2001) Autoimmunity in Chagas heart disease. Int J Parasitol 31:555–561
Leon, JS, Godsel, LM, Wang, K, Engman, DM (2001) Cardiac myosin autoimmunity in acute Chagas’ heart disease. Infect Immun 69:5643–5649
Leon, JS, Wang, K, Engman, DM (2003) Myosin autoimmunity is not essential for cardiac inflammation in acute Chagas’ disease. J Immunol 171:4271–4277
Levin, MJ (1996) In chronic chagas heart disease, don’t forget the parasite. Parasitol. Today 12:415–416
Levin, MJ, Levitus, G, Kerner, N, Lafon, S, Schijman, A, Levy-Yeyati, P, Finkieltein, C, Chiale, P, Schejtman, D, Hontebeyrie-Joskowics, M (1990) Autoantibodies in Chagas’ heart disease: possible markers of severe Chagas’ heart complaint. Mem Inst Oswaldo Cruz 85:539–543
Levin, MJ, Mesri, E, Benarous, R, Levitus, G, Schijman, A, Levy-Yeyati, P, Chiale, PA, Ruiz, AM, Kahn, A, Rosenbaum, MB, et al. (1989) Identification of major Trypanosoma cruzi antigenic determinants in chronic Chagas’ heart disease. Am J Trop Med Hyg 41:530–538
Levitus, G, Hontebeyrie-Joskowicz, M, Van Regenmortel, MH, Levin, MJ (1991) Humoral autoimmune response to ribosomal P proteins in chronic Chagas heart disease. Clin Exp Immunol 85:413–417
Lopez Bergami, P, Cabeza Meckert, P, Kaplan, D, Levitus, G, Elias, F, Quintana, F, Van Regenmortel, M, Laguens, R, Levin, MJ (1997) Immunization with recombinant Trypanosoma cruzi ribosomal P2beta protein induces changes in the electrocardiogram of immunized mice. FEMS Immunol Med Microbiol 18:75–85
Lopez Bergami, P, Scaglione, J, Levin, MJ (2001) Antibodies against the carboxylterminal end of the Trypanosoma cruzi ribosomal P proteins are pathogenic. FASEB J 15:2602–2612
Mahler, E, Hoebeke, J, Levin, MJ (2004) Structural and functional complexity of the humoral response against the Trypanosoma cruzi ribosomal P2 beta protein in patients with chronic Chagas’ heart disease. Clin Exp Immunol 136:527–534
Mahler, E, Sepulveda, P, Jeannequin, O, Liegeard, P, Gounon, P, Wallukat, G, Eftekhari, P, Levin, MJ, Hoebeke, J, Hontebeyrie, M (2001) Amonoclonal antibody against the immunodominant epitope of the ribosomal P2beta protein of Trypanosoma cruzi interacts with the human beta 1-adrenergic receptor. Eur J Immunol 31:2210–2216
Marino, AP, Azevedo, MI, Lannes-Vieira, J (2003a) Differential expression of adhesion molecules shaping the T-cell subset prevalence during the early phase of autoimmune and Trypanosoma cruzi-elicited myocarditis. Mem Inst Oswaldo Cruz 98:945–952
Marino, AP, Silva, AA, Pinho, RT, Lannes-Vieira, J (2003b) Trypanosoma cruzi infection: a continuous invader-host cell cross talk with participation of extracellular matrix and adhesion and chemoattractant molecules. Braz J Med Biol Res 36:1121–1133
Martin, D, Tarleton, R (2004) Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection. Immunol Rev 201:304–317
Mazza, S (1949) La enfermedad de Chagas en la Rep. Argentina. Mem Inst. Oswaldo Cruz 47:273–288
McCormick, TS, Rowland, EC (1989) Trypanosoma cruzi: cross-reactive anti-heart autoantibodies produced during infection in mice. Exp Parasitol 69:393–401
Moncayo, A (1999) Progress towards interruption of transmission of Chagas disease. Mem Inst Oswaldo Cruz 94Suppl 1:401–404
Monteon-Padilla, V, Hernandez-Becerril, N, Ballinas-Verdugo, MA, Aranda-Fraustro, A, Reyes, PA (2001) Persistence of Trypanosoma cruzi in chronic chagasic cardiopathy patients. Arch Med Res 32:39–43
Morris, SA, Tanowitz, HB, Wittner, M, Bilezikian, JP (1990) Pathophysiological insights into the cardiomyopathy of Chagas’ disease. Circulation 82:1900–1909
Muñoz-Fernandez, MA, Fernandez, MA, Fresno, M (1992) Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur J Immunol 22:301–307
Neu, N, Ploier, B, Ofner, C (1990) Cardiac myosin-induced myocarditis. Heart autoantibodies are not involved in the induction of the disease. J Immunol 145:4094–4100
Neu, N, Rose, NR, Beisel, KW, Herskowitz, A, Gurri-Glass, G, Craig, SW (1987) Cardiac myosin induces myocarditis in genetically predisposed mice. J Immunol 139:3630–3636
Nitz, N, Gomes, C, de Cassia Rosa, A, D’souza-Ault, MR, Moreno, F, Lauria-Pires, L, Nascimento, RJ, Teixeira, AR (2004) Heritable integration of kDNA minicircle sequences from Trypanosoma cruzi into the avian genome: insights into human Chagas disease. Cell 118:175–186
Nomura, Y, Yoshinaga, M, Haraguchi, T, Oku, S, Noda, T, Miyata, K, Umebayashi, Y, Taira, A (1994) Relationship between the degree of injury at operation and the change in antimyosin antibody titer in the postpericardiotomy syndrome. Pediatr Cardiol 15:116–120
Oldstone, MB (1989) Overview: infectious agents as etiologic triggers of autoimmune disease. Curr Top Microbiol Immunol 145:1–3
Olivieri, BP, Cotta-De-Almeida, V, Araujo-Jorge, T (2002) Benznidazole treatment following acute Trypanosoma cruzi infection triggers CD8+ T-cell expansion and promotes resistance to reinfection. Antimicrob Agents Chemother 46:3790–3796
Palomino, AS, Aiello, V.D., Higuchi, M.L. (2000) Systematic mapping of hearts from chronic chagasic patients: the association between the occurrence of histopathological lesions and Trypanosoma cruzi antigens. Ann Trop Med Parasitol 6:571–579
Penninger, JM, Bachmaier, K (2000) Review of microbial infections and the immune response to cardiac antigens. J Infect Dis 181Suppl 3:S498–504
Pereira Barretto, AC, Mady, C, Arteaga-Fernandez, E, Stolf, N, Lopes, EA, Higuchi, ML, Bellotti, G, Pileggi, F (1986) Right ventricular endomyocardial biopsy in chronic Chagas’ disease. Am Heart J 111:307–312
Petkova, SB, Huang, H, Factor, SM, Pestell, RG, Bouzahzah, B, Jelicks, LA, Weiss, LM, Douglas, SA, Wittner, M, Tanowitz, HB (2001) The role of endothelin in the pathogenesis of Chagas’ disease. Int J Parasitol 31:499–511
Pollevick, GD, Sanchez, DO, Campetella, O, Trombetta, S, Sousa, M, Henriksson, J, Hellman, U, Pettersson, U, Cazzulo, JJ, Frasch, AC (1993) Members of the SAPA/transsialidase protein family have identical N-terminal sequences and a putative signal peptide. Mol Biochem Parasitol 59:171–174
Pontes-de-Carvalho, L, Santana, CC, Soares, MB, Oliveira, GG, Cunha-Neto, E, Ribeirodos-Santos, R (2002) Experimental chronic Chagas’ disease myocarditis is an autoimmune disease preventable by induction of immunological tolerance to myocardial antigens. J Autoimmun 18:131–138
Prata, A (1994) Chagas’ disease. Infect Dis Clin North Am 8:61–76
Prata, A (2001) Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 1:92–100
Reis, DD, Jones, EM, Tostes, S, Lopes, ER, Chapadeiro, E, Gazzinelli, G, Colley, DG, McCurley, TL (1993) Expression of major histocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas’ disease. Am J Trop Med Hyg 49:192–200
Ribeiro-Dos-Santos, R, Mengel, JO, Postol, E, Soares, RA, Ferreira-Fernandez, E, Soares, MB, Pontes-De-Carvalho, LC (2001) A heart-specific CD4+ T-cell line obtained from a chronic chagasic mouse induces carditis in heart-immunized mice and rejection of normal heart transplants in the absence of Trypanosoma cruzi. Parasite Immunol 23:93–101
Rose, NR (2001) Infection, mimics, and autoimmune disease. J Clin Invest 107:943–944
Rose, NR, Hill, SL (1996) The pathogenesis of postinfectious myocarditis. Clin Immunol Immunopathol 80:S92–99
Rose, NR, Mackay, IR (2000) Molecular mimicry: a critical look at exemplary instances in human diseases. Cell Mol Life Sci 57:542–551
Rossi, L (1996) Neuropathology of chronic chagasic cardiopathy: A diagnostic reassessment. Cardiovasc Pathol 5:233–239.
Santos-Buch, CA, Teixeira, AR (1974) The immunology of experimental Chagas’ disease. 3. Rejection of allogeneic heart cells in vitro. J Exp Med 140:38–53
Sepulveda, P, Liegeard, P, Wallukat, G, Levin, MJ, Hontebeyrie, M (2000) Modulation of cardiocyte functional activity by antibodies against Trypanosoma cruzi ribosomal P2 protein C terminus. Infect Immun 68:5114–5119
Silva, JS, Morrissey, PJ, Grabstein, KH, Mohler, KM, Anderson, D, Reed, SG (1992) Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J Exp Med 175:169–174
Skeiky, YA, Benson, DR, Parsons, M, Elkon, KB, Reed, SG (1992) Cloning and expression of Trypanosoma cruzi ribosomal protein P0 and epitope analysis of anti-P0 autoantibodies in Chagas’ disease patients. J Exp Med 176:201–211
Smith, SC, Allen, PM (1992) Expression of myosin-class II major histocompatibility complexes in the normal myocardium occurs before induction of autoimmune myocarditis. Proc Natl Acad Sci U S A 89:9131–9135
Soares, MB, Pontes-De-Carvalho, L, Ribeiro-Dos-Santos, R (2001) The pathogenesis of Chagas’ disease: when autoimmune and parasite-specific immune responses meet. An Acad Bras Cienc 73:547–559
Stauffer, Y, Marguerat, S, Meylan, F, Ucla, C, Sutkowski, N, Huber, B, Pelet, T, Conrad, B (2001) Interferon-alpha-induced endogenous superantigen. A model linking environment and autoimmunity. Immunity 15:591–601
Sterin-Borda, L, Giordanengo, L, Joensen, L, Gea, S (2003) Cruzipain induces autoantibodies against cardiac muscarinic acetylcholine receptors. Functional and pathological implications. Eur J Immunol 33:2459–2468
Takle, GB, Hudson, L (1989) Autoimmunity and Chagas’ disease. Curr Top Microbiol Immunol 145:79–92
Talvani, A, Ribeiro, CS, Aliberti, JC, Michailowsky, V, Santos, PV, Murta, SM, Romanha, AJ, Almeida, IC, Farber, J, Lannes-Vieira, J, Silva, JS, Gazzinelli, RT (2000) Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect 2:851–866
Tanowitz, HB, Kirchhoff, LV, Simon, D, Morris, SA, Weiss, LM, Wittner, M (1992) Chagas’ disease. Clin Microbiol Rev 5:400–419
Tarleton, RL (2001) Parasite persistence in the aetiology of Chagas disease. Int J Parasitol 31:550–554
Tarleton, RL (2003) Chagas disease: a role for autoimmunity? Trends Parasitol 19:447–451
Tarleton, RL, Zhang, L (1999) Chagas disease etiology: autoimmunity or parasite persistence? Parasitol Today 15:94–99
Tarleton, RL, Zhang, L, Downs, MO (1997) “Autoimmune rejection” of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue. Proc Natl Acad Sci U S A 94:3932–3937
Teixeira Vde, P, Araujo, MB, dos Reis, MA, dos Reis, L, Silveira, SA, Rodrigues, ML, Franquini Junior, J (1993) Possible role of an adrenal parasite reservoir in the pathogenesis of chronic Trypanosoma cruzi myocarditis. Trans R Soc Trop Med Hyg 87:552–554
Torrico, F, Heremans, H, Rivera, MT, Van Marck, E, Billiau, A, Carlier, Y(1991) Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J Immunol 146:3626–3632
Vago, AR, Macedo, AM, Adad, SJ, Reis, DD, Correa-Oliveira, R (1996) PCR detection of Trypanosoma cruzi DNA in oesophageal tissues of patients with chronic digestive Chagas’ disease. Lancet 348:891–892
Vakkila, J, Aysto, S, Saarinen-Pihkala, UM, Sariola, H (2001) Naive CD4+ T cells can be sensitized with IL-7. Scand J Immunol 54:501–505
Van Voorhis, WC, Schlekewy, L, Trong, HL (1991)Molecularmimicry by Trypanosoma cruzi: the F1-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide. Proc Natl Acad Sci U S A 88:5993–5997
Vianna, G (1911) Contribuiçao para o estudo da anatomia patologica da Molestia de Carlos Chagas’. Mem Inst Oswaldo Cruz 3:276–293
Viotti, R, Vigliano, C, Armenti, H, Segura, E (1994) Treatment of chronic Chagas’ disease with benznidazole: clinical and serologic evolution of patients with long-term follow-up. Am Heart J 127:151–162
von Herrath, MG, Fujinami, RS, Whitton, JL (2003) Microorganisms and autoimmunity: making the barren field fertile? Nat Rev Microbiol 1:151–157
Wendel, S (1998) Transfusion-transmitted Chagas’ disease. Curr Opin Hematol 5:406–411
Wood, JN, Hudson, L, Jessell, TM, Yamamoto, M(1982) A monoclonal antibody defining antigenic determinants on subpopulations of mammalian neurones and Trypanosoma cruzi parasites. Nature 296:34–38
Wucherpfennig, KW (2001) Structural basis of molecular mimicry. J Autoimmun 16:293–302
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gironès, N., Cuervo, H., Fresno, M. (2005). Trypanosoma cruzi-Induced Molecular Mimicry and Chagas’ Disease. In: Oldstone, M.B. (eds) Molecular Mimicry: Infection-Inducing Autoimmune Disease. Current Topics in Microbiology and Immunology, vol 296. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30791-5_6
Download citation
DOI: https://doi.org/10.1007/3-540-30791-5_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-25597-0
Online ISBN: 978-3-540-30791-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)